Non-invasive prenatal diagnostic is an emerging genetic test that is used to screen for the birth defects and inherited diseases. The test utilizes small amount of the babies DNA to screen the down syndrome, trisomy 14 and 18, along with the inherited diseases such as cystic fibrosis, hemophilia, and other conditions.

The non-invasive prenatal diagnostics market is expected to grow in the forecast period owing to key factors such as rise in the population, increase in the demand for the non-invasive prenatal diagnostic testing products and others. The market is likely to experience the growth opportunities in the emerging nations and the technological advancements are likely to develop innovative products.

The "Global Non-invasive Prenatal Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global non-invasive prenatal diagnostics market with detailed market segmentation by product, application, end user and geography. The global non-invasive prenatal diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Non-invasive prenatal diagnostics market players and offers key trends and opportunities in the market.

The global non-invasive prenatal diagnostics market is segmented on the basis of product, application and end user. Based product, the market is segmented as instruments and consumables. On the basis of the application the market segmentation is classified as microdeletion syndrome, trisomy and others. Based on the end user the market is segmented as hospitals, diagnostics laboratories and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global non-invasive prenatal diagnostics market based on product, application and end user. It also provides market size and forecast till 2028 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-invasive prenatal diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the non-invasive prenatal diagnostics market in the forecast period. Asia Pacific is anticipated to be the fastest growing region due to the increasing number of pregnancies, increasing risk of premature deliveries due to unhealthy lifestyle and increase in the demand of the NIPT products.

The report analyzes factors affecting non-invasive prenatal diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-invasive prenatal diagnostics market in these regions.

The report also includes the profiles of key non-invasive prenatal diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the non-invasive prenatal diagnostics market include, Thermo Fisher Scientific, Inc., Illumina, Inc., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen, F. Hoffmann-La Roche Ltd, BGI, Agilent Technologies, Inc., Eurofins Scientific and Quest Diagnostics Incorporated.